{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-001712","form_type":"8-K","ticker":"CATX","cik":"0000728387","company_name":"Perspective Therapeutics, Inc.","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.210778+00:00","generated_at":"2026-05-28T11:43:26.253654+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Perspective Therapeutics appoints Juan Graham as CFO; Jonathan Hunt remains CAO","bullets":["Juan Graham appointed CFO effective Jan 6, 2025; Jonathan Hunt steps down as CFO but stays CAO.","Graham brings 25 years experience; previously CFO of FibroGen, finance leadership at Johnson & Johnson.","Annual base salary $500k, target bonus 40%, signing bonus $80k, option grant of 400k shares with 4-year vest.","Severance: 12 months salary plus pro-rated bonus and COBRA upon termination without cause or for good reason.","Change of control: accelerated vesting of equity; severance of 12 months salary if not retained or termination within 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-001712","json":"https://secwatch.observer/filing/0000950170-25-001712.json","markdown":"https://secwatch.observer/filing/0000950170-25-001712.md","text":"https://secwatch.observer/filing/0000950170-25-001712.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/catx-20250102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T11:43:26.253654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f7ce7f1d6","claim":"Jonathan Hunt changed role as Chief Financial Officer at Perspective Therapeutics, Inc..","evidence_excerpt":"As of the Effective Date, Mr. Jonathan Hunt will no longer serve as the Company’s Chief Financial Officer but will remain in his role as the Company’s Chief Accounting Officer and principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will no longer serve"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"1011e2b322","claim":"Juan Graham was appointed as Chief Financial Officer at Perspective Therapeutics, Inc..","evidence_excerpt":"On January 2, 2025, the Board of Directors (the “Board”) of Perspective Therapeutics, Inc. (the “Company”) appointed Mr. Juan Graham as the Company’s Chief Financial Officer and principal financial officer, in each case effective as of January 6, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025001712/0000950170-25-001712-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}